Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
Published June 5, 2019 · Recall initiated: May 3, 2019
Summary
FDA records drug Class II recall D-1308-2019, published June 5, 2019 and initiated May 3, 2019. Recalling firm: Avella of Deer Valley, Inc. Store 38; Status: Terminated; Reported quantity: 730 syringes; Lot: Lot #: 138-20191202@64, Exp 05/13/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Avella of Deer Valley, Inc. Store 38
- Distributor
- U.S.A. nationwide
- Lot
- Lot #: 138-20191202@64, Exp 05/13/19
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAINOFOAM Foaming E-2 Food Handling Wash with .6% PCMX, 1000mL pouch (NDC 058575-110-11), 6/1000 ML pouches perJune 5, 2019
- FDADrill, contra-angle, 1.5x85mm, Item Number ST502015706May 29, 2019
- FDAMAGnesium 2 gm sulfate, added to NS 50 mL, Sterile single use bag, 54 mL, Compounded by Avella SpecialtyFebruary 20, 2019
- FDABEVACIZUMAB 2.5 MG/0.1ML, pre-filled syringe (deliverable dose of 1.25MG in normject syringe) Repackaged byNovember 14, 2018
- FDAMorphine (1 mg/mL) in NS 100 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and Avella ofNovember 7, 2018
- FDAPhenylephrine 25 mg added to NS 250 mL Bag, Rx only, Advanced Pharma, Inc. d/b/a Avella of Houston, and AvellaNovember 7, 2018
Questions about this recall
Was Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27 recalled?
Yes. FDA published recall D-1308-2019 on June 5, 2019. Reported hazard: Lack of assurance of sterility
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit